Literature DB >> 20924583

A novel point mutation within the juxtamembrane domain of the flt3 gene in acute myeloid leukemia.

Valentina Gianfelici, Daniela Diverio, Massimo Breccia, Sonia Buffolino, Valentina Derme, Attilio Di Lascio, Marilisa Marinelli, Simona Santangelo, Giovanna Meloni, Robin Foà.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20924583     DOI： 10.1007/s00277-010-1092-0

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  4 in total

1.  Deletions in FLT-3 juxtamembrane domain define a new class of pathogenic mutations: case report and systematic analysis.

Authors:  David J Young; Bao Nguyen; Ruiqi Zhu; Jaesung Seo; Li Li; Mark J Levis; Keith W Pratz; Amy S Duffield; Donald Small
Journal:  Blood Adv       Date:  2021-05-11

Review 2.  An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment.

Authors:  Tiziana Grafone; Michela Palmisano; Chiara Nicci; Sergio Storti
Journal:  Oncol Rev       Date:  2012-04-17

3.  The Current State of FLT3 Inhibition in Acute Myeloid Leukemia - Pitfalls and Promises.

Authors:  Katherine A Minson; Deborah DeRyckere; Douglas K Graham
Journal:  J Cell Signal       Date:  2017-10-16

4.  Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD.

Authors:  Sebastian Stasik; Michael Kramer; Sven Zukunft; Christoph Röllig; Claudia D Baldus; Uwe Platzbecker; Hubert Serve; Carsten Müller-Tidow; Kerstin Schäfer-Eckart; Martin Kaufmann; Stefan Krause; Tim Sauer; Mathias Hänel; Andreas Neubauer; Gerhard Ehninger; Martin Bornhäuser; Johannes Schetelig; Jan M Middeke; Christian Thiede
Journal:  Front Oncol       Date:  2022-03-21       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.